NUK - logo
E-viri
Recenzirano Odprti dostop
  • Transporters in Drug Develo...
    Zamek‐Gliszczynski, Maciej J.; Taub, Mitchell E.; Chothe, Paresh P.; Chu, Xiaoyan; Giacomini, Kathleen M.; Kim, Richard B.; Ray, Adrian S.; Stocker, Sophie L.; Unadkat, Jashvant D.; Wittwer, Matthias B.; Xia, Cindy; Yee, Sook‐Wah; Zhang, Lei; Zhang, Yan

    Clinical pharmacology and therapeutics, November 2018, Letnik: 104, Številka: 5
    Journal Article

    This white paper provides updated International Transporter Consortium (ITC) recommendations on transporters that are important in drug development following the 3rd ITC workshop. New additions include prospective evaluation of organic cation transporter 1 (OCT1) and retrospective evaluation of organic anion transporting polypeptide (OATP)2B1 because of their important roles in drug absorption, disposition, and effects. For the first time, the ITC underscores the importance of transporters involved in drug‐induced vitamin deficiency (THTR2) and those involved in the disposition of biomarkers of organ function (OAT2 and bile acid transporters).